These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 16696473)
81. AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137. Nath R; Bice WS; Butler WM; Chen Z; Meigooni AS; Narayana V; Rivard MJ; Yu Y; Med Phys; 2009 Nov; 36(11):5310-22. PubMed ID: 19994539 [TBL] [Abstract][Full Text] [Related]
82. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom. Chiu-Tsao ST; Medich D; Munro J Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938 [TBL] [Abstract][Full Text] [Related]
83. Use and uncertainties of mutual information for computed tomography/ magnetic resonance (CT/MR) registration post permanent implant of the prostate. Roberson PL; McLaughlin PW; Narayana V; Troyer S; Hixson GV; Kessler ML Med Phys; 2005 Feb; 32(2):473-82. PubMed ID: 15789594 [TBL] [Abstract][Full Text] [Related]
84. Technical and dosimetric aspects of iodine-125 seed reimplantation in suboptimal prostate implants. Marcu LG; Lawson JM Br J Radiol; 2013 Jun; 86(1026):20130058. PubMed ID: 23520225 [TBL] [Abstract][Full Text] [Related]
85. Loose versus stranded seeds in permanent prostate brachytherapy: dosimetric comparison of intraoperative plans. Major T; Agoston P; Fröhlich G; Baricza K; Szabo Z; Jorgo K; Herein A; Polgar C Phys Med; 2014 Dec; 30(8):909-13. PubMed ID: 25175151 [TBL] [Abstract][Full Text] [Related]
86. Dosimetric comparison between model 9011 and 6711 sources in prostate implants. Zhang H; Beyer D Med Dosim; 2013; 38(2):199-203. PubMed ID: 23510715 [TBL] [Abstract][Full Text] [Related]
87. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry. Xue J; Waterman F; Handler J; Gressen E Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069 [TBL] [Abstract][Full Text] [Related]
88. Hybrid dosimetry: feasibility of mixing angulated and parallel needles in planning prostate brachytherapy. Fu L; Liu H; Ng WS; Rubens D; Strang J; Messing E; Yu Y Med Phys; 2006 May; 33(5):1192-8. PubMed ID: 16752554 [TBL] [Abstract][Full Text] [Related]
89. Recommendations of the American Association of Physicists in Medicine regarding the impact of implementing the 2004 task group 43 report on dose specification for 103Pd and 125I interstitial brachytherapy. Williamson JF; Butler W; Dewerd LA; Huq MS; Ibbott GS; Mitch MG; Nath R; Rivard MJ; Todor D; Med Phys; 2005 May; 32(5):1424-39. PubMed ID: 15984693 [TBL] [Abstract][Full Text] [Related]
90. Polymer gel dosimetry close to an 125I interstitial brachytherapy seed. Pantelis E; Lymperopoulou G; Papagiannis P; Sakelliou L; Stiliaris E; Sandilos P; Seimenis I; Kozicki M; Rosiak JM Phys Med Biol; 2005 Sep; 50(18):4371-84. PubMed ID: 16148399 [TBL] [Abstract][Full Text] [Related]
92. Computing intraoperative dosimetry for prostate brachytherapy using TRUS and fluoroscopy. French D; Morris J; Keyes M; Goksel O; Salcudean S Acad Radiol; 2005 Oct; 12(10):1262-72. PubMed ID: 16179203 [TBL] [Abstract][Full Text] [Related]
93. Dosimetric comparison between bone marrow sparing intensity-modulated radiation therapy and conventional techniques in the treatment of cervical cancer: a retrospective study. Sundaram T; Nagarajan V; Nagarajan M; Jayakumar S; Govindarajan KN; Supe SS; Balasubramaniam M; Joshi P; Chellapandian TP Gulf J Oncolog; 2013 Jan; 1(13):30-41. PubMed ID: 23339979 [TBL] [Abstract][Full Text] [Related]
94. Impact of edema and seed movement on the dosimetry of prostate seed implants. Sloboda RS; Usmani N; Monajemi TT; Liu DM J Med Phys; 2012 Apr; 37(2):81-9. PubMed ID: 22557797 [TBL] [Abstract][Full Text] [Related]
95. Seed Placement in Permanent Breast Seed Implant Brachytherapy: Are Concerns Over Accuracy Valid? Morton D; Hilts M; Batchelar D; Crook J Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):1050-1057. PubMed ID: 27020105 [TBL] [Abstract][Full Text] [Related]
96. Impact of interseed attenuation and tissue composition for permanent prostate implants. Carrier JF; Beaulieu L; Therriault-Proulx F; Roy R Med Phys; 2006 Mar; 33(3):595-604. PubMed ID: 16878563 [TBL] [Abstract][Full Text] [Related]
97. SU-E-T-07: Edema Induced Changes in Tumor Cell Survival Fraction and Tumor Control Probability in 131Cs Permanent Prostate Implant Patients. Kehwar TS; Huq MS; Smith RP Med Phys; 2012 Jun; 39(6Part9):3703. PubMed ID: 28519040 [TBL] [Abstract][Full Text] [Related]
98. Dosimetry of a thyroid uptake detected in seed migration survey following a patient's iodine-125 prostate implant and in vitro measurements of intentional seed leakages. Chen QS; Russell JL; Macklis RR; Weinhous MS; Blair HF Med Phys; 2006 Jul; 33(7):2384-90. PubMed ID: 16898440 [TBL] [Abstract][Full Text] [Related]